stocksPGHL
PGHL

Procter & Gamble Health Ltd.

6,612.00+349.5 (+5.58%)
9 Jul, 3:30 PM

Annual Reports and Financial Documents

Procter & Gamble Health Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Procter & Gamble Health Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20183 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Dear Sir, Please find attached signed certificate for confirming compliance under Regulation 74 (5) of the SEBI (DP) Regulations, for the quarter ended June 30, 2026.
  • General26 Jun 2026
    Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited ('The Company')
    Dear Sir, Please find attached communication in respect of deduction of TDS on the amount of final dividend income from the Company, if approved by the shareholders at the ensuing AGM.
  • Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Dear Sir, Please find attached our intimation for closure of trading window.
  • Board Meeting26 Jun 2026
    Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6, 2026
    Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Dear Sir, In terms ....
  • Change in Management25 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Pursuant to regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you regarding changes in the Senior Management Personnel of the Company shall take place effective July 1, 2026.
  • Analyst / Investor Meet18 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    The Company has informed the Stock Exchange regarding the transcript and link to the recording of the analyst/institutional investors meeting held earlier today.
  • Analyst / Investor Meet18 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    The Company has informed the Stock Exchange regarding the Presentation of the Analyst/Institutional investor meet scheduled to be held today.
  • Analyst / Investor Meet4 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts ....
  • Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Please find attached signed Annual Secretarial Compliance report for the year ended March 31, 2026
  • Record Date26 May 2026
    Record Date For Purpose Of Dividend
    Record date for purpose of dividend
  • Dividend26 May 2026
    Corporate Action-Board approves Dividend
    Board has recommended final dividend for the Financial Year 2025-26, subject to approval of shareholders.
  • Press Release / Media Release26 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Please find attached press release for the quarter and financial year ended March 31, 2026.
  • Change in Management26 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Dear Sir, Please find attached intimation for re appointment of Independent Director.
  • Outcome of Board Meeting26 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On May 26, 2026
    We are enclosing herewith the following: a. Audited Financial Results for the Financial Year ended March 31, 2026, as per format prescribed under Regulation 33 of Securities Exchange Board ....
  • General30 Apr 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Sale Of Immovable Properties
    Dear Sir, Please find attached our intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015. Request you to kindly take the same on record.
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A6 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Dear Sir/Madam, Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations, for the quarter ended March 31, 2026.
  • Board Meeting27 Mar 2026
    Board Meeting Intimation for Intimation Of Board Meeting
    Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Intimation of Board ....
  • Closure of Trading Window27 Mar 2026
    Closure of Trading Window
    Intimation for closure of trading window
  • General6 Feb 2026
    Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited
    Dear Sir, Please find attached communication in respect of deduction of TDS on the amount of dividend income from declaration of interim dividend for the Financial year 2025-26.

Frequently Asked Questions

Where can I download the annual report of Procter & Gamble Health Ltd.?
Annual reports of Procter & Gamble Health Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Procter & Gamble Health Ltd.?
Quarterly earnings results and presentations of Procter & Gamble Health Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Procter & Gamble Health Ltd. publish earnings call transcripts?
Earnings call transcripts of Procter & Gamble Health Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Procter & Gamble Health Ltd.?
Investor presentations and annual day presentations of Procter & Gamble Health Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Procter & Gamble Health Ltd.?
Corporate announcements and regulatory filings of Procter & Gamble Health Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Procter & Gamble Health Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Procter & Gamble Health Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Procter & Gamble Health Ltd.?
The ISIN (International Securities Identification Number) of Procter & Gamble Health Ltd. is INE199A01012. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Procter & Gamble Health Ltd. listed?
Procter & Gamble Health Ltd. is listed on NSE and BSE. The NSE symbol is PGHL and the BSE code is -.
Where can I find the shareholding pattern of Procter & Gamble Health Ltd.?
The quarterly shareholding pattern of Procter & Gamble Health Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Procter & Gamble Health Ltd. on Sharpely?
Share price data for Procter & Gamble Health Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.